US 6136307
Reovirus for the treatment of cellular proliferative disorders
expired A61KA61K35/765A61K9/0019
Quick answer
US patent 6136307 (Reovirus for the treatment of cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon Oct 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Oct 24 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K35/765, A61K9/0019, A61P, A61P31/12